CE for Nurses
The Managing HL CE for Nurses section contains continuing educational activities focused on evidence-based scientific data and resources for nurses treating patients with Hodgkin lymphoma.
Stay up-to-date with recent advances in the management of HL and earn valuable continuing education contact hours.
 | Appropriate Treatment Approaches in Patients Through Every Stage of Hodgkin Lymphoma CNE Jonathon B. Cohen, MD, MS; Catherine Diefenbach, MD; Alison J. Moskowitz, MD; Sarah Rutherford, MD | |
| Release Date: June 26, 2019 Expiration Date: June 26, 2020 | ||
This activity will address several practice-related issues regarding the management and treatment of patients with Hodgkin lymphoma (HL). Nurses who provide care to patients with HL may encounter clinical challenges regarding appropriate treatments and the adverse events associated with them. In this activity, you will hear from four experts focusing on topics including, but not limited to: emerging treatment regimens for newly diagnosed HL, recent clinical trials that are making an impact on the frontline management of advanced-stage cHL, current salvage treatment options for relapsed/refractory cHL, and CD30-directed therapy. Provided by MediCom Worldwide, Inc. | ||
| View Only, CE ExpiredView Only, No Credit | ||
 | Evolving Care Strategies in Newly Diagnosed HL: Emerging Therapies and the Changing Role of the Oncology Nurse CNE Amy L. Goodrich, RN, MSN, CRNP; Mollie E. Moran, MSN, CNP, AOCNP | |
| Release Date: December 06, 2018 Expiration Date: December 06, 2019 | ||
| New and emerging therapies are changing the treatment paradigms and care of patients with newly diagnosed advanced Hodgkin lymphoma. This symposium replay takes a closer look at these changes and their impact to nursing care. Our presenters provide an overview of the therapeutic treatment options and their known side-effect profiles which, if left unmanaged, could impact the overall progress and quality of life for patients. This activity includes presentations from our expert faculty on best strategies to employ in recognizing, treating, and long-term management of adverse events. We encourage you to listen in as faculty discuss the day-to-day educational needs of patients being treated for cHL. Provided by MediCom Worldwide, Inc. This activity is supported by an educational grant from Seattle Genetics, Inc. | ||
| View Only, CE ExpiredView Only, No Credit | ||